- Home
- SVRA vs DIN Comparison
SVRA vs DIN Comparison
Compare SVRA & DIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- DIN
- Stock Information
- Founded
- SVRA 2007
- DIN 1958
- Country
- SVRA United States
- DIN United States
- Employees
- SVRA N/A
- DIN N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- DIN Restaurants
- Sector
- SVRA Health Care
- DIN Consumer Discretionary
- Exchange
- SVRA Nasdaq
- DIN Nasdaq
- Market Cap
- SVRA 433.8M
- DIN 379.1M
- IPO Year
- SVRA N/A
- DIN 1991
- Fundamental
- Price
- SVRA $2.58
- DIN $24.52
- Analyst Decision
- SVRA Buy
- DIN Hold
- Analyst Count
- SVRA 5
- DIN 9
- Target Price
- SVRA $5.60
- DIN $26.86
- AVG Volume (30 Days)
- SVRA 1.3M
- DIN 355.9K
- Earning Date
- SVRA 08-11-2025
- DIN 08-06-2025
- Dividend Yield
- SVRA N/A
- DIN 8.33%
- EPS Growth
- SVRA N/A
- DIN N/A
- EPS
- SVRA N/A
- DIN 3.61
- Revenue
- SVRA N/A
- DIN $820,851,000.00
- Revenue This Year
- SVRA N/A
- DIN $8.51
- Revenue Next Year
- SVRA N/A
- DIN $1.83
- P/E Ratio
- SVRA N/A
- DIN $6.78
- Revenue Growth
- SVRA N/A
- DIN N/A
- 52 Week Low
- SVRA $1.89
- DIN $18.63
- 52 Week High
- SVRA $4.74
- DIN $37.44
- Technical
- Relative Strength Index (RSI)
- SVRA 59.80
- DIN 48.12
- Support Level
- SVRA $2.25
- DIN $22.70
- Resistance Level
- SVRA $2.39
- DIN $26.48
- Average True Range (ATR)
- SVRA 0.15
- DIN 0.90
- MACD
- SVRA 0.04
- DIN -0.02
- Stochastic Oscillator
- SVRA 88.61
- DIN 48.15
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About DIN Dine Brands Global Inc.
Dine Brands Global Inc owns and franchises thousands of restaurants under the Applebee's and International House of Pancakes names. Almost all company restaurants are located in the United States and franchised. Royalty revenue, which the company gets from franchisees based on franchisees' sales, accounts for roughly three-quarters of total company revenue. The company also earns revenue by leasing restaurant sites to franchisees. The company has four reportable segments Franchise operations, (an aggregation of Applebee's and IHOP franchise operations), Rental operations, Financing operations and Company-operated restaurant operations. The majority of revenue is derived from the Franchise operations segment.